Vivanza Biosciences logo

Vivanza Biosciences

VIVANZABIOSCIENCESLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹7.50 Cr
Volatility
Moderate
P/E Ratio
17.1
EBITDA
₹0.80 Cr
Return on Equity
9.05%
Debt to Equity
2
Book Value
₹1.09
EPS
₹0.08
52W High
₹2.72
52W Low
₹1.52

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Debtor days have improved from 196 to 39.0 days.

Weaknesses

4
  • Promoter holding is low: 20.0%
  • Company has a low return on equity of 2.11% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -27.8%

Growth Rate

Revenue Growth
—
Net Income Growth
-157% lower than 3Y
Cash Flow Change
-3.2% higher than 3Y
ROE
-153% lower than 3Y
ROCE
-465% lower than 3Y
EBITDA Margin (Avg.)
-118% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
9.23
7.62
6.56
4.42
2.44
3
1.5
0.48
8.94
55.36
45.25
6.36
9.29
Expenses
8.64
7.3
6.27
4.56
2.08
2.89
1.37
1.44
8.79
54.75
45.04
6.59
9.36
Operating Profit
0.59
0.32
0.29
-0.14
0.36
0.11
0.13
-0.96
0.15
0.61
0.21
-0.23
-0.07
OPM %
6.39%
4.2%
4.42%
-3.17%
14.75%
3.67%
8.67%
-200%
1.68%
1.1%
0.46%
-3.62%
-0.75%
Other Income
0.01
0.05
0.02
-0.03
0
0
0.01
0.05
0.02
0.01
0.08
0.01
0.37
Interest
0.11
0.11
0.1
0.09
0.09
0.09
0.09
0.08
0.08
0.05
0.09
0.07
0.11
Depreciation
0
0
0
0.01
0
0
0
0
0
0
0
0.01
0.01
PBT
0.49
0.26
0.21
-0.27
0.27
0.02
0.05
-0.99
0.09
0.57
0.2
-0.3
0.18
Tax %
0%
0%
0%
55.56%
0%
0%
0%
1.01%
0%
0%
0%
50%
22.22%
Net Profit
0.49
0.26
0.21
-0.41
0.27
0.02
0.04
-1
0.09
0.56
0.2
-0.45
0.15
EPS in Rs
0.12
0.06
0.05
-0.1
0.07
0
0.01
-0.25
0.02
0.14
0.05
-0.11
0.04
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
3
6
3
10
10
10
18
28
7
116
116
Expenses
0
4
6
3
10
10
10
17
27
8
115
116
Operating Profit
0
0
1
0
0
0
0
1
1
0
1
1
OPM %
—
-9%
9%
-0.8%
-3.6%
0.9%
-0.6%
3.8%
3.9%
-4.9%
0.6%
0.5%
Other Income
0
0
0
0
1
1
1
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
1
1
-1
1
1
Tax %
0%
0%
13%
0%
0%
42%
0%
17%
21%
2%
27%
—
Net Profit
0
0
0
0
0
0
0
1
1
-1
0
0
EPS in Rs
-0.32
-0.08
0.05
-0.11
-0.05
0.02
0.08
0.15
0.14
-0.17
0.1
0.12
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.19
4
4
4
4
4
4
4
4
4
4
Reserves
0
0
0
-1
-1
-1
-1
0
1
0
0
Borrowings
0
1
1
1
0
0
6
8
5
9
10
Other Liabilities
0
3
5
6
9
5
7
10
10
4
8
Total Liabilities
1
7
10
11
12
8
16
22
20
16
22
Fixed Assets
0
2
2
2
2
2
2
2
2
2
2
CWIP
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1
5
8
9
10
6
13
20
17
14
20
Total Assets
1
7
10
11
12
8
16
22
20
16
22
Figures in ₹ Crores

Cash Flow

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
-2
0
1
3
-3
2
-1
2
-2
-3
Investing
0
2
0
0
0
0
0
0
0
0
0
Financing
0
0
-1
-1
-3
3
-2
1
-2
2
3
Net Cash Flow
0
0
-1
0
0
0
0
0
0
0
0
Free Cash Flow
0
-2
0
1
3
-3
2
-1
2
-3
-3
CFO/OP
0
668
-15
-4,300
-876
-3,367
-4,117
-124
203
692
-328
Figures in ₹ Crores

Ratios

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
267
287
782
250
231
275
256
151
398
39
Inventory Days
—
215
150
309
38
26
92
55
28
121
11
Days Payable
—
304
319
878
319
154
207
211
116
140
23
Cash Conversion Cycle
—
178
118
213
-32
103
160
99
64
379
27
Working Capital Days
—
332
237
469
109
104
103
50
44
154
7
ROCE %
—
-10%
13%
0%
6%
17%
12%
11%
10%
-3%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vivanza Biosciences insights

53 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

Public73.49%Others6.49%Promot.20.02%As ofJun 2026

Documents

Frequently Asked Questions about Vivanza Biosciences

What does Vivanza Biosciences Ltd do?
Incorporated in 2016, Vivanza Biosciences Ltd is in the business of providing medicines and healthcare solutions[1]
Where is Vivanza Biosciences Ltd (530057) listed?
Vivanza Biosciences Ltd trades as VIVANZABIOSCIENCESLTD on the NSE and under code 530057 on the BSE.
Which sector does Vivanza Biosciences Ltd belong to?
Vivanza Biosciences Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Vivanza Biosciences Ltd?
Vivanza Biosciences Ltd has a market capitalisation of ₹7.5 Cr, which places it in the Small Cap band.
What is the PE ratio of Vivanza Biosciences Ltd?
Vivanza Biosciences Ltd trades at a PE ratio of 17.10, on earnings per share of ₹0.08, against a book value of ₹1.09 per share.
What is the 52-week high and low of Vivanza Biosciences Ltd?
Over the last 52 weeks Vivanza Biosciences Ltd has traded between ₹1.52 and ₹2.72.
What is the Return on Equity (ROE) of Vivanza Biosciences Ltd?
Vivanza Biosciences Ltd reported a return on equity of 9.05%. Its debt-to-equity ratio is 2.00.

Company Information

Incorporated in 2016, Vivanza Biosciences Ltd is in the business of providing medicines and healthcare solutions[1]

Website vivanzabiosciences.com
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530057.md for Vivanza Biosciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List